The United States continues to face a range of serious threats to its national health security from the deliberate use or accidental release of chemical, biological, radiological, and nuclear (CBRN) agents, as well as from naturally occurring and emerging infectious diseases (EID), including pandemic influenza. The Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) coordinates Federal efforts to ensure that our nation is prepared with the medical countermeasures it needs to meet the challenges posed by CBRN and EID threats.
This two-day workshop will highlight past progress and future directions in developing, stockpiling and effectively utilizing the drugs, vaccines, and devices that may be required in public health emergencies caused by either naturally occurring epidemics or intentional chemical, biological, radiological and nuclear attacks.
The workshop will feature a mix of plenary sessions and in-depth breakout sessions along four tracks:
- PHEMCE Preparedness Goals and Operational Capacity
- Clinical Guidance on the use of Medical Countermeasures
- Challenges of collecting post-marketing data on safety and efficacy for MCMs approved under the animal rule
- The Strategic National Stockpile
- Revised MCM Requirements process combined with Risk Assessments
- Science Needs during Crisis Response
- Biosafety and Biosecurity
- Focusing on Populations with Special Needs
- How Can We Help You Make that Product?
- Accelerating Research Transitions: NIH Support and Services for Medical Countermeasure Development
- Combating Antibiotic Resistant Bacteria Program
- Past, Present and Future of the MCM Initiative at FDA
- The MERS CoV Connection
- Dealing with Emerging Infectious Diseases
- Ebola Response – After Action Report
- Influenza and respiratory pathogens update
Advance registration for this event is closed. Onsite registration may be available, space permitting.